Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push August 27, 2026Posted inBiotechnology Vivace Therapeutics has named Craig Gibbs, Ph.D., as its new president and CEO. Post navigation Previous Post Bidirectional Neural Network Advances Iterative Learning in End-to-End Wireless CommunicationNext PostA year on from Big Pharma’s pull-back from the UK, has anything changed?
